Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Pyrogen Testing Market – A Novel Approach for Detecting Pyrogen Contamination
Pyrogen testing plays a major role in advanced healthcare, as it shows the presence of pyrogen in an organism that causes fever. Pyrogen can be found in lipopolysaccharides and lepoteichoic acid. Contaminated pyrogenic products can cause harmful effects such as fever in human body.
The global pyrogen testing market size was valued at US$ US$ 689.9 million in 2017, and is expected to exhibit a CAGR of 12.4% over the forecast period (2018 – 2026).
Figure 1. Global Pyrogen Testing Market Value (US$ Mn), by Region, 2017
Source: Coherent Market Insights Analysis
Increasing demand for testing of pyrogen contamination in medical devices and drugs is expected to propel growth of the pyrogen testing market
Pyrogen testing is used in detection of pyrogen contamination in pharmaceutical dosage forms and medical devices. Pyrogen contaminated injections post administration can cause temperature dysregulation (fever), bodyache, inflammation, shock, multiorgan failure, and other life threatening problems.
Moreover, increasing research and development of therapeutic drugs and medical devices is propelling growth of the pyrogen testing market over the forecast period. According to the United Nations Educational, Scientific and Cultural Organization (UNESCO), November 2016, an estimated US$ 1.7 trillion of global spending in research and development for various medical applications. Moreover, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER), has approved around 59 novel drugs in 2018 compared to 46 approvals of new molecule entities in 2017.
Figure 2. Global Pyrogen Testing Market Share (%), by Test Type, 2018 and 2026
Source: Coherent Market Insights Analysis
Increasing research and development in healthcare sector in North America is expected to bolster the market growth
North America holds dominant position in the pyrogen testing market, owing to high prevalence of cardiovascular disease. According to the European Federation of Pharmaceutical Industries and Association (EFPIA) report, 2018, an estimated US$ 48,111 million and US$ 82,418 million pharmaceutical expenditure was recorded in 2015 and 2016 respectively, in the U.S.
Increasing number of approvals for new molecule entities (NMEs) by regulatory agencies in this region is expected to bolster the market growth over the forecast period. In 2018, the U.S. Food and Drug Administration (FDA), approved 59 new molecule entities which enables new treatment options for patients and advances in health care for the American people.
Moreover, key players in the market are focused on collaboration activities for development of new kits and reagents used in detection of pyrogen in pharmaceutical products and devices. For instance, in May 2018, Merck and Solvias announced collaboration plans to develop PyroMAT System, a new kit for detection of pyrogen.
Key Players
Major players operating in the global pyrogen testing market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMérieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar
US :
INDIA :
UK :
JAPAN :
U.S. :
+1-206-701-6702
UK :
+44-020-8133-4027
JAPAN :
+81-50-5539-1737
INDIA :
+91-848-285-0837
Sales Office (U.S.) : 
